Cognitive impairment in breast cancer patients before surgery: results from a CANTO cohort subgroup.
Fiche publication
Date publication
juillet 2020
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles
Tous les auteurs :
Lange M, Hardy-Léger I, Licaj I, Pistilli B, Rigal O, Le Fel J, Lévy C, Capel A, Coutant C, Meyer J, Lerebours F, Petrucci J, Vanlemmens L, Brion M, Campone M, Soulié P, Blain M, Vaz-Luis I, Giffard B, Martin AL, Everhard S, André F, Dauchy S, Joly F
Lien Pubmed
Résumé
20-30% of breast cancer patients have cognitive impairment after surgery and before adjuvant treatment, but very few studies have focused on cognition before any treatment. The present study used a subgroup of women with newly diagnosed breast cancer patients from the French cancer and toxicities (CANTO) cohort to describe cognition before any treatment in comparison to a group of healthy controls (HC).
Référence
Cancer Epidemiol. Biomarkers Prev.. 2020 Jul 1;: